Percentage of children newly prescribed attention-deficit/hyperactivity disorder (ADHD) medication who had at least three follow-up care visits within a 10-month period, one of which is within 30 days of when the first ADHD medication was dispensed.
An Initiation Phase Rate and Continuation and Maintenance Phase Rate are reported.
Measure Specs
General Information
Numerator
Among children newly prescribed ADHD medication, those who had timely and continuous follow-up visits.
Denominator
Children 6-12 years of age newly prescribed ADHD medication.
Exclusions
Children who had an acute inpatient encounter for mental health or chemical dependency following the Index Prescription Start Date
Children with a diagnosis of narcolepsy: Many of the medications used to identify patients for the denominator of this measure are also used to treat narcolepsy. Children with narcolepsy who are pulled into the denominator are then removed by the narcolepsy exclusion.
Children using hospice services during the measurement year. Children in hospice may not be able to receive the necessary follow-up care.
Measure Record
Point of Contact
© 2020 by the National Committee for Quality Assurance
1100 13th Street, NW, 3rd floor
Washington, DC 20005
Public Comments